ShockWave Medical Inc buy BiotechBee
Start price
07.09.22
/
70%
€285.40
Target price
31.12.25
€400.00
Performance (%)
-47.00%
End price
12.11.23
€151.25
Summary
This prediction ended on 12.11.23 with a price of €151.25. Massive losses of -47.00% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| ShockWave Medical Inc | - | - | - | - |
| iShares Core DAX® | 0.048% | 1.311% | 11.378% | 62.793% |
| iShares Nasdaq 100 | 1.601% | -0.902% | 7.287% | 90.940% |
| iShares Nikkei 225® | 3.057% | 12.947% | 33.767% | 70.774% |
| iShares S&P 500 | 0.820% | 0.703% | 4.930% | 61.763% |
According to BiotechBee what are the pros and cons of ShockWave Medical Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread ShockWave Medical Inc diskutieren
Buy mit Kursziel 400,0